|
|
 |
Washington Convention Center, Washington, DC – February 22, 2006 This online CME activity is based on the educational session "Patch Delivery" held at the 2006 World Parkinson Congress in Washington, DC. Persons who attended the symposium are NOT eligible for AMA PRA Category 1 Credit™ for completing this enduring material. Please note that the course is accredited only for physicians (MD, DO, or equivalent). All other participants receive a certificate of completion.
Statement of Need Parkinson disease is a progressive movement disorder that affects nearly 1 million US adults. Approximately 40,000 people are diagnosed with Parkinson disease each year in the United States. Although a cure does not presently exist, surgical and pharmacotherapeutic advances have led to improved treatment options and delivery methods for patients with Parkinson disease. Activity Purpose This activity was developed to apprise clinicians of the role of the transdermal patch in antiparkinsonian drug delivery for the treatment of Parkinson disease. Specific disease management concepts, novel delivery methods, and the emerging role of the rotigotine transdermal system in the treatment of patients with advanced-stage Parkinson disease are discussed. Learning Objectives After completing this activity, participants should be able to
Accreditation/Planning The Movement Disorder Society (MDS) is accredited by the ACCME to provide continuing medical education for physicians. Designation of Credit MDS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Policy MDS requires that CME faculty disclose, during the planning of an activity, the existence of any personal financial or other relationships they or their spouses/partners have with the commercial supporter of the activity or with the manufacturer of any commercial product or service discussed in the activity. Off-label Discussion This CME activity may include discussions regarding the use of medications that may be outside of the approved labeling for these products. Physicians should consult the current prescribing information for these products. MDS requires faculty members to disclose that a product is not yet labeled for the use under discussion or to state that the product is still investigational. Faculty Disclosures and Biographies Anthony Lang, MD, FRCP Dr Lang is a professor of neurology in the Department of Medicine at the University of Toronto in Toronto, Canada. He is also the director of the Morton and Gloria Shulman Movement Disorders Clinic at the Toronto Western Hospital and the Jack Clark Chair in Parkinson Disease Research at the University of Toronto. Dr Lang is also the director of the Division of Neurology at the University of Toronto. After receiving his training in medicine and neurology at the University of Toronto, Dr Lang completed a clinical research fellowship with Professor C.D. Marsden at King's College Hospital and the Institute of Psychiatry in London, England. In 1982, following his fellowship, Dr Lang returned to Toronto, where he then developed the Movement Disorders Clinic at the Toronto Western Hospital. Dr Lang’s research has involved all aspects of Parkinson disease and other movement disorders and can be found in more than 220 peer-reviewed publications in leading medical journals. He is one of the founders of the Parkinson Study Group and the International Movement Disorder Society, and he has served on the executive board of both groups. Dr Lang is a past Co-Editor-in-Chief of the journal Movement Disorders. Kapil Sethi, MD, FRCP Dr Sethi is a professor of neurology at the Medical College of Georgia in Augusta. He also serves as director of the Movement Disorders Clinic and the National Parkinson Foundation Center of Excellence and as a staff physician at the Augusta Veterans Affairs Medical Center. An author of numerous reviews, abstracts, book chapters, and journal articles, Dr Sethi’s work is published in numerous peer-reviewed publications, including the Journal of the American Medical Association, Neurology, and Movement Disorders. With research interests in Parkinson disease, restless legs syndrome, and cervical dystonia, Dr Sethi has participated as principal investigator in numerous clinical trials and research studies. He is frequently invited to lecture and has held visiting professorships at Albany Medical College, the University of Virginia, and the University of Missouri, among others. Dr Sethi is a fellow of the American Academy of Neurology and the Royal College of Physicians and a member of the American Neurological Association, the Movement Disorder Society, and the American Association of Physicians from India. Dr Sethi received his medical degree from Christian Medical College, Ludhiana, India. He completed a residency in internal medicine at the Post Graduate Institute of Medical Education and Research, Chandigarh, India, where he also received fellowship training in neurology. Dr Sethi continued his medical education by completing a research fellowship in neurology at the Charing Cross Group of Hospitals and Medical School in London, England. In addition, he was a registrar in neurology at the Welsh National School of Medicine at Morriston Hospital and completed a neurology residency at the Medical College of Georgia. Cheryl Waters, MD, FRCP Dr Waters is a professor of clinical neurology and chief of Clinical Practice and Services, Division of Movement Disorders at Columbia University in New York, New York. She has been involved in research on the genetics and treatment of Parkinson disease and has been an investigator in numerous studies involving a variety of new medical and surgical treatments. Dr Waters was named the first Albert B. and Judith L. Glickman Professor of Clinical Neurology at Columbia University. She has authored numerous articles and book chapters and has 1 book in its third edition. Instructions to Participants Course participants must view all presentations and complete both the course test and the course evaluation in order to receive CME credit. No fees are charged to participate in the program or to receive the certificate. Full instructions are available on the user instructions page. Disclaimer The opinions expressed herein are those of the faculty and do not necessarily represent the views of the grantor, provider, or publisher. Please review complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients. Medicine is a constantly changing science, and clearly established therapies are not always available for every condition. New research findings necessitate continual changes in drug and treatment therapies. Reasonable efforts have been made to provide up-to-date, accurate information that is within generally accepted medical standards at the time of publication. However, as medical science is ever evolving, and human error is always possible, the grantor, provider, and publisher (or any other involved party) do not guarantee total accuracy or comprehensiveness of the information in this article, and they are not responsible for omissions or errors, or the results of using information provided in this course. Participants should confirm the accuracy of the information in this activity from other sources. In particular, all drug doses, indications, and contraindications should be confirmed in package inserts. Content Ownership Statement The content of this enduring educational activity has been generated from the 2006 World Parkinson Congress and is therefore the property of the Movement Disorder Society. No part of this material may be reproduced in any form or by any means without the prior written permission of the Movement Disorder Society. Click here to view minimum system requirements.
|
